Trial Profile
A European Multicenter Open-Label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Cephalon
- 02 Oct 2012 Results (n=330) presented at the 37th Congress of the European Society of Medical Oncology.
- 19 Sep 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 31 Aug 2012 Quality-of-life and efficacy results presented at the 14th World Congress on Pain.